TCM
OKUR

Tang Capital Management’s OnKure Therapeutics OKUR Stock Holding History

Tang Capital Management’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-116,395
Closed -$320K – 200
2025
Q3 		$320K Sell
116,395
-52,850
-31% -$131K 0.01% 190
2025
Q2 		$404K Sell
169,245
-230,755
-58% -$605K 0.02% 191
2025
Q1 		$1.72M Buy
400,000
+105,374
+36% +$593K 0.1% 130
2024
Q4 		$2.53M Hold
294,626
– – 0.17% 98
2024
Q3 		$5.01M Sell
294,626
-5,000
-2% -$74K 0.36% 74
2024
Q2 		$4.52M Sell
299,626
-74
-0% -$1.25K 0.46% 62
2024
Q1 		$4.98M Sell
299,700
-33,300
-10% -$549K 0.52% 60
2023
Q4 		$5.33M Buy
+333,000
New +$20.8M 0.49% 50
2023
Q1 		– Sell
-3,059
Closed -$71.3K – 121
2022
Q4 		$71.3K Buy
+3,059
New +$81.1K 0.01% 88

Other funds holding OKUR

ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return

Tang Capital Management's OKUR Position: Q4 2025 in Review

Tang Capital Management sold out of OnKure Therapeutics (OKUR) in Q4 2025, closing a stake of 116,395 shares — an estimated $320K sold.

Tang Capital Management first reported a position in OKUR in Q4 2022 and held it in 9 quarters. The position peaked at $5.33M in Q4 2023. 44 funds tracked by Wall St. Rank hold OKUR as of Q4 2025.

  • Tang Capital Management reported no remaining OnKure Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Tang Capital Management sold 116,395 OnKure Therapeutics shares in Q4 2025, an estimated $320K.
  • Tang Capital Management first reported a position in OnKure Therapeutics in Q4 2022 and held it in 9 quarters.
  • Tang Capital Management's OnKure Therapeutics position peaked at $5.33M in Q4 2023.
  • 44 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q4 2025.

Based on Tang Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.